BDBM638394 Preparation of (S)-10-((Dimethylamino)methyl)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl 4-(6-(4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluorobenzamido)hexyl)piperazine-1-carboxylate ::US11834458, Example 6

SMILES CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(OC(=O)N5CCN(CCCCCCNC(=O)c6ccc(cc6F)N6C(=O)N(C(=O)C6(C)C)c6ccc(C#N)c(c6)C(F)(F)F)CC5)c(CN(C)C)c4cc3Cn1c2=O

InChI Key InChIKey=HTDCCDRCFUBEPC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 638394   

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM638394(US11834458, Example 6 | Preparation of (S)-10-((Di...)
Affinity DataIC50: 255nMAssay Description:To assess AR binding, test compound (top dose 10 μM, 4 fold serial dilution, 8 point dose response) and control (progesterone) were transferred ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2024
Entry Details
US Patent